Showing results (321-330 of 617) with videos related to

Sort By:
Pageof 62
Journal of Psychosocial Oncology|December 2, 2008
Case-control comparison of quality of life in long-term ovarian germ cell tumor survivors: a gynecologic oncology group studyPatrick O Monahan, Victoria L Champion, Qianqian Zhao, et al.
Obstetrics and Gynecology|May 1, 1986
Urinary conduits in gynecologic oncologyK C Hancock, L J Copeland, D M Gershenson, et al.
Obstetrics and Gynecology|October 1, 1985
Tamoxifen therapy of epithelial ovarian cancerD R Shirey, J J Kavanagh, D M Gershenson, et al.
Obstetrics and Gynecology Clinics of North America|June 1, 1996
Ovarian intraepithelial neoplasia and ovarian cancerD M Gershenson, G Tortolero-Luna, A Malpica, et al.
Cancer|May 15, 1997
Prognostic factors in adult granulosa cell tumor of the ovaryB E Miller, B A Barron, J Y Wan, et al.
Gynecologic Oncology|September 1, 1992
Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC)C Levenback, T W Burke, E Silva, et al.
Gynecologic Oncology|September 22, 2022
Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survivalDavid M Gershenson, Lauren P Cobb, Shannon N Westin, et al.
American Journal of Obstetrics and Gynecology|May 1, 1989
Gracilis myocutaneous vaginal reconstruction concurrent with total pelvic exenterationL J Copeland, K C Hancock, D M Gershenson, et al.
Gynecologic Oncology|March 30, 1999
Growth suppression of human ovarian cancer cell lines by the introduction of a p16 gene via a recombinant adenovirusJ K Wolf, T E Kim, D Fightmaster, et al.
Gynecologic Oncology|January 1, 1993
Treatment of advanced or recurrent squamous cell carcinoma of the uterine cervix with mitomycin-C, bleomycin, and cisplatin chemotherapyH O Smith, C A Stringer, J J Kavanagh, et al.
Pageof 62